SCHEMBL4822933

SCHEMBL4822933

Cc1ncn(-c2ccccc2CNC(=O)c2nc3n(c(=O)c2O)CCCOC32CCOCC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 2/20 0.37
PDE9A O76083 1/20 0.36
RIPK1 Q13546 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
PIK3CD O00329 1/20 0.33
CNR2 P34972 1/20 0.33
BRD4 O60885 1/20 0.33
BRD9 Q9H8M2 1/20 0.33
KCNH2 Q12809 1/20 0.32
CYP2C9 P11712 1/20 0.32
TP53 P04637 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
THRB P10828 1/20 0.32
EGLN1 Q9GZT9 1/20 0.31
F2 P00734 1/20 0.31
CALCA P06881 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826458 0.90 CYP2C9 (0.38) CNR2KCNH2CYP2C9EGLN1CALCA
SCHEMBL3836159 0.85 CYP2C9 (0.34) RIPK1KCNH2CYP2C9EGLN1
SCHEMBL4824125 0.85 CYP2C9 (0.39) RIPK1CNR2KCNH2CYP2C9THRB
SCHEMBL5621796 0.85 LIPG (0.36) LIPGPDE9ARIPK1SCN2ASCN10A
SCHEMBL4832696 0.82 CYP2C9 (0.36) RIPK1KCNH2CYP2C9THRBEGLN1
SCHEMBL3836168 0.82 CYP2C9 (0.36) RIPK1KCNH2CYP2C9THRBEGLN1
SCHEMBL5621820 0.79 CYP2C9 (0.40) RIPK1CNR2KCNH2CYP2C9SMN1; SMN2
SCHEMBL4832292 0.79 KCNH2 (0.35) KCNH2CYP2C9EGLN1
SCHEMBL2081447 0.79 CYP2C9 (0.34) RIPK1PIK3CDKCNH2CYP2C9EGLN1
SCHEMBL3836949 0.78 F2 (0.39) LIPGPDE9ASCN2ASCN10AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7419969-B2 HIV integrase inhibitors: cyclic pyrimidinone compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2008-09-02 US claimed
US-7419969-B2 HIV integrase inhibitors: cyclic pyrimidinone compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2008-09-02 US disclosed
US-7419969-B2 HIV integrase inhibitors: cyclic pyrimidinone compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2008-09-02 US disclosed
US-7419969-B2 HIV integrase inhibitors: cyclic pyrimidinone compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2008-09-02 US disclosed
WO-2007058646-A1 HIV INTEGRASE INHIBITORS: CYCLIC PYRIMIDINONE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-24 WO disclosed